Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Keiko Furihata is active.

Publication


Featured researches published by Keiko Furihata.


The Journal of Antibiotics | 2005

Prunustatin A, a Novel GRP78 Molecular Chaperone Down- regulator Isolated from Streptomyces violaceoniger

Yukiko Umeda; Shuhei Chijiwa; Kazuo Furihata; Keiko Furihata; Shohei Sakuda; Hiromichi Nagasawa; Hidenori Watanabe; Kazuo Shin-ya

In the course of our screening program for regulators of a molecular chaperone GRP78 expression, we isolated a novel inhibitor of GRP78 expression, designated as prunustatin A, from Streptomyces violaceoniger 4521-SVS3. The structure of prunustatin A was determined by a series of NMR analyses to be an oxidized type of the neoantimycin family. Prunustatin A inhibited the expression of GRP78 induced by 2-deoxyglucose in human fibrosarcoma HT1080 cells accompanied by global cell death without showing cytotoxicity under normal nutrient condition.


The Journal of Antibiotics | 2006

Thioviridamide, a Novel Apoptosis Inducer in Transformed Cells from Streptomyces olivoviridis

Yoichi Hayakawa; Kahori Sasaki; Hisashi Adachi; Keiko Furihata; Koji Nagai; Kazuo Shin-ya

In the course of screening for antitumor antibiotics using 3Y1 rat fibroblasts transformed with adenovirus oncogenes, a new active substance designated thioviridamide was isolated from the culture broth of an actinomycete. The producing organism was identified as Streptomyces olivoviridis on the basis of its culture characteristics and physiological properties. Thioviridamide showed cytotoxicity selectively against Ad12-3Y1 cells (IC50=3.9 ng/ml) and E1A-3Y1 cells (IC50=32 ng/ml), both of which contain the adenovirus E1A oncogene. Significant numbers of Ad12-3Y1 cells treated with thioviridamide contained condensed chromatin and fragmented nuclei, indicating that thioviridamide induced apoptosis.


Marine Biotechnology | 2002

Isolation and Characterization of 2-Nitroimidazole Produced by Streptomyces Species as an Inhibitor of Both Carbonic Anhydrase and Shell Formation in the Barnacle Balanus amphitrite

Mari Fukushima; Noriaki Ozaki; Hiroyuki Ikeda; Keiko Furihata; Yoichi Hayakawa; Shohei Sakuda; Hiromichi Nagasawa

Abstract: Carbonic anhydrase is thought to be involved in the process of calcium carbonate deposition in calcified tissues of many organisms. Barnacles form hard calcified shells for protection against predation, and represent a class of marine-fouling animals. In order to inhibit barnacle growth by inhibiting shell formation, we searched for carbonic anhydrase inhibitors from microbial secondary metabolites. A simple assay for assessing carbonic-anhydrase-inhibiting activity was developed. Screening of many microorganisms isolated from soil with this assay resulted in a microbial strain that produced a carbonic anhydrase inhibitor. This strain was identified as Streptomyces eurocidicus mf294. The inhibitor was isolated through 4 purification steps and identified as 2-nitroimidazole on the basis of spectroscopic data. 2-Nitroimidazole inhibited barnacle carbonic anhydrase dose-dependently and complete inhibition was reached at the concentration of 1 × 10−5 M. 2-Nitroimidazole did not affect settlement or metamorphosis of barnacle larvae, but inhibited shell formation at concentrations higher than 1 × 10−4 M. These findings strongly support the idea that carbonic anhydrase is involved in calcification.


Cellular and Molecular Life Sciences | 1981

Effect of detoxin D on blasticidin S uptake inBacillus cereus

Akira Shimazu; H. Yamaki; Keiko Furihata; Toyoshige Endo; Noboru Otake; Y. Yonehara

The active transport of blasticidin S into the cells ofBacillus cereus was significantly inhibited by the addition of detoxin D or poisons of energy metabolism.


The Journal of Antibiotics | 1995

A new neuronal cell protecting substance, lavanduquinocin, produced by Streptomyces viridochromogenes.

Kazuo Shin-ya; Shintaro Shimizu; Toshihiro Kunigami; Keiko Furihata; Kazuo Furihata; Haruo Seto


The Journal of Antibiotics | 1982

STUDIES ON MYCOTRIENIN ANTIBIOTICS, A NOVEL CLASS OF ANSAMYCINS

Masanori Sugita; Yohei Natori; Tetsuo Sasaki; Keiko Furihata; Akira Shimazu; Haruo Seto; Noboru Otake


The Journal of Antibiotics | 1985

NEORUSTMICIN A, A NEW MACROLIDE ANTIBIOTIC ACTIVE AGAINST WHEAT STEM RUST FUNGUS

Toshio Takatsu; Hiroshi Nakayama; Akira Shimazu; Keiko Furihata; Keiji Ikeda; Kazuo Furihata; Haruo Seto; Noboru Otake


The Journal of Antibiotics | 1991

Isolation and structural elucidation of pyridoxatin, a free radical scavenger of microbial origin.

Yoshihiro Teshima; Kazuo Shin-ya; Akira Shimazu; Keiko Furihata; Ha Sang Chul; Kazuo Furihata; Yoichi Hayakawa; Kazuo Nagai; Haruo Seto


The Journal of Antibiotics | 1999

Novel Antibiotics Pyrisulfoxin A and B Produced by Streptomyces californicus

Nobuaki Tsuge; Keiko Furihata; Kazuo Shin-ya; Yoichi Hayakawa; Haruo Seto


The Journal of Antibiotics | 1990

Isolation and structure of a new phenoxazine antibiotic, exfoliazone, produced by Streptomyces exfoliatus

Shinsuke Imai; Akira Shimazu; Keiko Furihata; Kazuo Furihata; Yoichi Hayakawa; Haruo Seto

Collaboration


Dive into the Keiko Furihata's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kazuo Shin-ya

National Institute of Advanced Industrial Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge